The role of IgG1 and IgG4 as dominant IgE-blocking antibodies shifts during allergen immunotherapy. Strobl MR, Demir H, Acosta GS, Drescher A, et al. J Allergy Clin Immunol 2023 Jan 16:S0091-6749(23)00036.

Read + Share

Amedeo Smart

Independent Medical Education

Strobl MR, Demir H, Acosta GS, Drescher A, et al. The role of IgG1 and IgG4 as dominant IgE-blocking antibodies shifts during allergen immunotherapy. J Allergy Clin Immunol 2023 Jan 16:S0091-6749(23)00036.
PMID: 36657603